NASDAQ:MTEM - Molecular Templates, Inc.
$7.47
 $0.07
+0.95%
4:00PM EDT
2019-07-22
Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. Evofosfamide is designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not in healthy tissues. Tarloxotinib is under investigation in two Phase II proof-of-concept trials: one for the treatment of patients with mutant EGFR-positive, T790M-negative advanced NSCLC progressing on an EGFR TKI, and the other for patients with recurrent or metastatic squamous cell carcinomas of the head and neck. [18F]-HX4 is an investigational Positron Emission Tomography imaging agent for hypoxia to identify. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MTEM     avg for
industry  
  avg for
sector  
42 stocks weight:  23. 11   217. 37   399. 45  
42 stocks rank:  3. 08 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  1. 70   2. 10   2. 04  

quick ratio:  3. 13   5. 49   1. 88  
current ratio:  3. 24   5. 87   2. 36  

target price low:  12. 00   83. 44   114. 90  
target price avg:  15. 25   106. 20   137. 90  
target price high:  18. 00   132. 30   158. 97  
1-yr high:  8. 46   111. 86   142. 57  
last close:  7. 40   86. 79   125. 44  
50-day avg:  7. 67   86. 68   122. 63  
200-day avg:  5. 74   89. 22   121. 38  
1-yr low:  3. 35   69. 78   100. 51  
volume:  46. 32 K 2. 62 M 3. 43 M
50-day avg volume:  113. 23 K 3. 20 M 4. 16 M
200-day avg volume:  102. 59 K 2. 99 M 4. 75 M

1-day return:  -2. 50 % -1. 30 % -0. 99 %
this week return:  1. 65 % 0. 45 % -0. 20 %
12-wk return:  9. 63 % 0. 94 % 4. 84 %
52-wk return:  47. 67 % -1. 30 % 10. 55 %

enterprise value (EV):  202. 49 M 45. 10 B 122. 38 B
market cap:  272. 09 M 38. 96 B 108. 40 B
EBITDA:  -27. 14 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -7. 46   5. 38   11. 93  
enterprise/revenue (EV/R):  10. 22   57. 92   10. 21  
total revenue:  19. 81 M 9. 91 B 39. 98 B
total debt:  13. 97 M 10. 90 B 17. 48 B
debt/equity:  14. 53   57. 18   120. 05  
net income (common):  -27. 74 M 2. 07 B 4. 05 B

shares outstanding:  36. 76 M 538. 09 M 1. 24 B
shares:  15. 80 M 548. 00 M 1. 22 B
shares short:  402. 78 K 10. 98 M 11. 87 M
shares short prior month:  296. 83 K 9. 32 M 12. 05 M
short ratio:  2. 84   5. 60   3. 34  
short % of float:  1. 74 % 6. 48 % 2. 64 %
total cash/share:  2. 27   10. 98   9. 19  
total cash:  83. 58 M 5. 93 B 6. 10 B
free cash flow:  -2. 52 M 2. 92 B 4. 55 B
operating cash flow:  -6. 46 M 3. 80 B 5. 78 B

book value:  2. 62   13. 35   27. 45  
price/book:  2. 83   4. 60   8. 78  
gross profits:  -16. 92 M 7. 44 B 36. 13 B
operating margins:  -142. 67 % -308. 40 % -28. 55 %
EBITDA margins:  -137. 01 % 13. 17 % 23. 38 %
profit margins:  -140. 03 % 10. 44 % 14. 18 %
gross margins:  -61. 37 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 87   2. 10   4. 23  
forward EPS:  -1. 20   3. 45   7. 10  
P/E:  -8. 55   1. 90   32. 10  
forward P/E:  -6. 17   6. 46   15. 47  
PE/G:  -0. 01   0. 70   -0. 54  
growth:  1353. 90 % 265. 63 % 79. 11 %
earnings high:  -0. 19   0. 89   1. 68  
earnings avg:  -0. 23   0. 70   1. 57  
earnings low:  -0. 28   0. 46   1. 46  
revenue high:  6. 60 M 2. 57 B 11. 07 B
revenue avg:  5. 01 M 2. 51 B 10. 91 B
revenue low:  3. 30 M 2. 45 B 10. 73 B
return on assets:  -15. 51 % -2. 34 % 5. 28 %
return on equity:  -33. 21 % -90. 08 % 133. 53 %
revenue growth:  1353. 90 % 265. 25 % 73. 68 %
revenue/share:  0. 62   12. 72   60. 04  

beta (1yr vs S&P500):  1. 61   1. 27   0. 91  
sharpe (1yr):  0. 85   0. 16   0. 77  

held % insiders:  12. 75 % 6. 06 % 3. 29 %
held % institutions:  72. 60 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MTEM
.     107.46 =        107.46 :: --> INITIAL WEIGHT <--
.    - 0.866 =       106.594 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.223 =       236.906 :: P/E factor
.    x 2.209 =       523.315 :: PE/G factor
.    x 1.576 =       824.722 :: beta factor
.    x 0.944 =       778.777 :: sharpe factor
.    x 2.552 =      1987.157 :: current ratio factor
.    x 1.212 =      2408.696 :: quick ratio factor
.    x 1.163 =      2800.841 :: short ratio factor
.    x 3.848 =     10777.678 :: revenue growth factor
.    x 1.176 =      12679.45 :: EV/R factor
.    x 1.027 =     13018.876 :: price-to-book factor
.    x 1.418 =     18459.558 :: debt-to-revenue factor
.     x 1.12 =      20672.67 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     43842.454 :: sector+industry 1-year gains factor
.    x 1.009 =     44255.804 :: industry 12-weeks return factor
.    x 1.308 =      57881.66 :: industry 2-weeks return factor
.    x 1.591 =     92095.601 :: 5-day avg > 200-day avg
.    x 1.336 =    123047.723 :: 50-day avg > 200-day avg
.    x 0.992 =    122024.706 :: "drift" penalty 2 days ago
.    x 0.982 =    119888.407 :: "drift" penalty 5 days ago
.    / 2.027 =     59159.114 :: overall "drift" factor
.    x 0.865 =     51174.975 :: largest single-day jump factor
.    x 0.102 =      5232.615 :: low price factor
.    x 0.465 =      2432.914 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.944 =       2295.74 :: forward EPS factor
.     x 0.98 =      2248.703 :: forward P/E factor
.    x 1.185 =      2664.067 :: industry recommendation factor
.    x 2.442 =      6504.567 :: company recommendation factor
.    x 1.003 =      6522.554 :: factor historical industry gain for week 29
.    x 1.978 =      12903.04 :: target low factor
.    x 1.343 =     17332.897 :: target mean factor
.     x 1.05 =     18204.177 :: target high factor
.   x 11.238 =    204574.426 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        21.267 :: reduced for readability
.    + 1.842 =        23.109 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     23.109 :: FINAL WEIGHT for NASDAQ:MTEM


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org